1. Home
  2. VVOS vs RDHL Comparison

VVOS vs RDHL Comparison

Compare VVOS & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$0.18

Market Cap

4.8M

Sector

Health Care

ML Signal

HOLD

Logo Redhill Biopharma Ltd.

RDHL

Redhill Biopharma Ltd.

HOLD

Current Price

$0.65

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VVOS
RDHL
Founded
2016
2009
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8M
4.0M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
VVOS
RDHL
Price
$0.18
$0.65
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
14.3M
2.4M
Earning Date
04-15-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
6.76
N/A
EPS
N/A
N/A
Revenue
$17,443,000.00
N/A
Revenue This Year
$69.66
$381.91
Revenue Next Year
$48.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.05
N/A
52 Week Low
$0.16
$0.57
52 Week High
$3.70
$2.79

Technical Indicators

Market Signals
Indicator
VVOS
RDHL
Relative Strength Index (RSI) 31.62 46.55
Support Level $0.16 $0.62
Resistance Level $0.55 $0.85
Average True Range (ATR) 0.04 0.11
MACD -0.00 0.00
Stochastic Oscillator 8.21 5.98

Price Performance

Historical Comparison
VVOS
RDHL

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About RDHL Redhill Biopharma Ltd.

RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.

Share on Social Networks: